Results 251 to 260 of about 718,683 (284)

The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems

Pharmaceutics, 2022
Xiaoling Xu
exaly  

PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies

Cancers, 2020
Elizabeth Lee, Ursula Matulonis
exaly  

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines

International Journal of Molecular Sciences, 2021
Waisse Waissi, Carole Mura, Georges Noel   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann S de Bono, Timothy A Yap, Shahneen Sandhu   +2 more
exaly  

PARP Inhibitors

2014
Joaquin Mateo, Timothy A. Yap, Johann S. De Bono   +2 more
openaire   +1 more source

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell, 2018
Marieke van de Ven, Haico van Attikum, Marcel van Vugt   +2 more
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells

Trends in Cell Biology, 2019
Haico van Attikum, Sylvie Noordermeer
exaly  

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

EBioMedicine, 2018
Zhixin Ma, Xin Huang, Chenying Li
exaly  

DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity

DNA Repair, 2015
Hein Te Riele, Atiq Faramarz, Eunike Velleuer   +2 more
exaly